These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 39255876)

  • 1. Hot Melt Extruded High-Dose Amorphous Solid Dispersions Containing Lumefantrine and Soluplus.
    Li S; Zhang Z; Gu W; Gallas M; Jones D; Boulet P; Johnson LM; de Margerie V; Andrews GP
    Int J Pharm; 2024 Nov; 665():124676. PubMed ID: 39255876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
    Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
    Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
    Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
    Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study between hot-melt extrusion and spray-drying for the manufacture of anti-hypertension compatible monolithic fixed-dose combination products.
    Kelleher JF; Gilvary GC; Madi AM; Jones DS; Li S; Tian Y; Almajaan A; Senta-Loys Z; Andrews GP; Healy AM
    Int J Pharm; 2018 Jul; 545(1-2):183-196. PubMed ID: 29730176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of hot melt extrusion for improving bioavailability of artemisinin a thermolabile drug.
    Kulkarni C; Kelly AL; Gough T; Jadhav V; Singh KK; Paradkar A
    Drug Dev Ind Pharm; 2018 Feb; 44(2):206-214. PubMed ID: 29145748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
    Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
    Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hot melt extrusion technology for improved dissolution, solubility and "spring-parachute" processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms.
    Shi NQ; Wang SR; Zhang Y; Huo JS; Wang LN; Cai JH; Li ZQ; Xiang B; Qi XR
    Eur J Pharm Sci; 2019 Mar; 130():78-90. PubMed ID: 30684657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
    Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
    AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hot melt extrusion versus spray drying: hot melt extrusion degrades albendazole.
    Hengsawas Surasarang S; Keen JM; Huang S; Zhang F; McGinity JW; Williams RO
    Drug Dev Ind Pharm; 2017 May; 43(5):797-811. PubMed ID: 27616147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design.
    Djuris J; Ioannis N; Ibric S; Djuric Z; Kachrimanis K
    J Pharm Pharmacol; 2014 Feb; 66(2):232-43. PubMed ID: 24350884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of the Polymer Type on the Quality of Newly Developed Oral Immediate-Release Tablets Containing Amiodarone Solid Dispersions Obtained by Hot-Melt Extrusion.
    Fița AC; Secăreanu AA; Musuc AM; Ozon EA; Sarbu I; Atkinson I; Rusu A; Mati E; Anuta V; Pop AL
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
    Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
    Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus
    Albadarin AB; Potter CB; Davis MT; Iqbal J; Korde S; Pagire S; Paradkar A; Walker G
    Int J Pharm; 2017 Oct; 532(1):603-611. PubMed ID: 28923766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
    Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
    Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine.
    Pina MF; Zhao M; Pinto JF; Sousa JJ; Craig DQ
    J Pharm Sci; 2014 Apr; 103(4):1214-23. PubMed ID: 24765654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing Drug Loading of Weakly Acidic Telmisartan in Amorphous Solid Dispersions through pH Modification during Hot-Melt Extrusion.
    Thompson SA; Davis DA; Moon C; Williams RO
    Mol Pharm; 2022 Jan; 19(1):318-331. PubMed ID: 34846902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Ternary Amorphous Solid Dispersions Manufactured by Hot-Melt Extrusion and Spray-Drying─Comparison of
    Trenkenschuh E; Blattner SM; Hirsh D; Hoffmann R; Luebbert C; Schaefer K
    Mol Pharm; 2024 Mar; 21(3):1309-1320. PubMed ID: 38345459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of lapatinib ditosylate solid dispersions using solvent rotary evaporation and hot melt extrusion for solubility and dissolution enhancement.
    Hu XY; Lou H; Hageman MJ
    Int J Pharm; 2018 Dec; 552(1-2):154-163. PubMed ID: 30268849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.